You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: April 1, 2026

Claims for Patent: 11,083,792

✉ Email this page to a colleague

Summary for Patent: 11,083,792

Title:	Purified antibody composition
Abstract:	The invention provides a method for producing a host cell protein-(HCP) reduced antibody preparation from a mixture comprising an antibody and at least one HCP, comprising an ion exchange separation step wherein the mixture is subjected to a first ion exchange material, such that the HCP-reduced antibody preparation is obtained.
Inventor(s):	Wan Min M., Avgerinos George, Zarbis-Papastoitsis Gregory
Assignee:	AbbVie Biotechnology Ltd
Application Number:	US16184374
Patent Claims:

Details for Patent 11,083,792

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Abbvie Inc.	HUMIRA	adalimumab	Injection	125057	December 31, 2002	11,083,792	2038-11-08
Abbvie Inc.	HUMIRA	adalimumab	Injection	125057	February 21, 2008	11,083,792	2038-11-08
Abbvie Inc.	HUMIRA	adalimumab	Injection	125057	April 24, 2013	11,083,792	2038-11-08
Abbvie Inc.	HUMIRA	adalimumab	Injection	125057	September 23, 2014	11,083,792	2038-11-08
Abbvie Inc.	HUMIRA	adalimumab	Injection	125057	November 23, 2015	11,083,792	2038-11-08
Abbvie Inc.	HUMIRA	adalimumab	Injection	125057	March 09, 2016	11,083,792	2038-11-08
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.